Prof. Dr. med. Caroline Voskens

Professur für Translationale Immundermatologie Department of Dermatology

Ein Lues-ähnliches Bild verursacht durch PVL-positive Staphylokokken (2023) Busch D, Schliep S, Berking C, Bosch-Voskens C Journal article Conventional and three-dimensional photography as a tool to map distribution patterns of in-transit melanoma metastases on the lower extremity (2023) Müller K, Berking C, Voskens C, Heppt M, Heinzerling L, Koch E, Kramer R, et al. Journal article Increased Motility and Suppression of Ex Vivo–Expanded Regulatory T Cells Designed for Adoptive Transfer Therapy in Ulcerative Colitis (2023) Müller T, Liu L, Czerwinski T, Wiesinger M, Dedden M, Paap EM, Ullrich K, et al. Journal article In vitro assessment of checkpoint-induced cytokine levels as new tool in the therapeutic decision-making process after checkpoint-induced cytokine release syndrome in metastatic melanoma (2022) Kramer R, Bender-Säbelkampf S, Berking C, Heppt M, Erdmann M, Bosch-Voskens C Conference contribution A single-center, retrospective Analysis for the Detection of Distant Metastases in Patients with regionally metastatic Melanoma in the Era of effective adjuvant Therapies (2022) Toussaint F, Kramer RA, Bender-Säbelkampf S, Hornung-Eichler A, Karimi B, Heppt M, Bosch-Voskens C, et al. Conference contribution Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets (2022) Becker E, Schweda A, Ullrich K, Voskens C, Atreya R, Müller T, Atreya I, et al. Journal article Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis (2022) Voskens C, Stoica D, Rosenberg M, Vitali F, Zundler S, Ganslmayer M, Knott H, et al. Journal article Editorial: Loss of Epithelial Barrier Integrity in Inflammatory Diseases: Cellular Mediators and Therapeutic Targets (2021) Weidinger C, Krug SM, Voskens C, Moschen AR, Atreya I Journal article, Editorial Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial (2021) Voskens C, Stoica D, Roessner S, Vitali F, Zundler S, Rosenberg M, Wiesinger M, et al. Journal article Detecting long-range interactions between migrating cells (2021) Metzner C, Hörsch F, Mark C, Czerwinski T, Winterl A, Voskens C, Fabry B Journal article